(2-乙酰氨基-5-氯苯基)乙酸甲酯 | 825619-15-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: (2-乙酰氨基-5-氯苯基)乙酸甲酯
• 英文名称: (2-Acetamido-5-chlorophenyl)methyl acetate
• CAS: 825619-15-6
• 化学式: C₁₁H₁₂ClNO₃
• 分子量: 241.674
• InChiKey: VYADGBWQRNPNKU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (2-乙酰氨基-5-氯苯基)乙酸甲酯 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 为溶剂， 反应 2.0h， 以0.44 g的产率得到(5-chloro-2-(ethylamino)phenyl)methanol
  参考文献：
  名称：

  Sunlight-Driven Forging of Amide/Ester Bonds from Three Independent Components: An Approach to Carbamates

  摘要：

  A photoredox catalytic route to carbamates enabled by visible irradiation (or simply sunlight) has been developed. This process leads to a novel approach to the construction of heterocyclic rings wherein the amide or ester motifs of carbamates were assembled from three isolated components. Large-scale experiments were realized by employing continuous flow techniques, and reuse of photocatalyst demonstrated the green and sustainable aspects of this method.

  DOI：

  10.1021/acs.orglett.6b02811
• 作为产物：
  描述：

  2-氨基-5-氯苯甲酸 在 sodium tetrahydroborate 、 碘 、 三乙胺 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 生成 (2-乙酰氨基-5-氯苯基)乙酸甲酯
  参考文献：
  名称：

  Sunlight-Driven Forging of Amide/Ester Bonds from Three Independent Components: An Approach to Carbamates

  摘要：

  A photoredox catalytic route to carbamates enabled by visible irradiation (or simply sunlight) has been developed. This process leads to a novel approach to the construction of heterocyclic rings wherein the amide or ester motifs of carbamates were assembled from three isolated components. Large-scale experiments were realized by employing continuous flow techniques, and reuse of photocatalyst demonstrated the green and sustainable aspects of this method.

  DOI：

  10.1021/acs.orglett.6b02811

文献信息

• Benzimidazole derivatives and their use as protein kinases inhibitors
  申请人：Berdini Valerio

  公开号：US20070135477A1

  公开（公告）日：2007-06-14

  The invention provides compounds of the formula (1): The compounds have activity against cyclin depdenent kinases, glycogen synthase kinase and Auroa kinases and are therefore useful to treat cancer and viral diseases.

  该发明提供了式（1）的化合物： 这些化合物具有对环素依赖性激酶、糖原合成酶激酶和Auroa激酶的活性，因此可用于治疗癌症和病毒性疾病。
• Benzimidazole derivatives and their use as protein kinase inhibitors
  申请人：Astex Therapeutics, Limited

  公开号：US07977477B2

  公开（公告）日：2011-07-12

  The invention provides compounds of the formula (I): The compounds have activity against cyclin dependent kinases, glycogen synthase kinase and Auroa kinases and are therefore useful to treat cancer and viral diseases.

  该发明提供了式(I)的化合物：这些化合物对于细胞周期依赖性激酶、糖原合成酶激酶和极化子激酶有活性，因此可用于治疗癌症和病毒性疾病。
• BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
  申请人：BERDINI Valerio

  公开号：US20110224203A1

  公开（公告）日：2011-09-15

  The invention provides compounds of the formula (I): The compounds have activity against cyclin dependent kinases, glycogen synthase kinase and Aurora kinases and are therefore useful to treat cancer and viral diseases.

  该发明提供了式(I)的化合物：这些化合物对于细胞周期依赖性激酶、糖原合成酶激酶和极化激酶具有活性，因此可用于治疗癌症和病毒性疾病。
• BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS
  申请人：Astex Therapeutics Limited

  公开号：EP1648426A2

  公开（公告）日：2006-04-26
• US7977477B2
  申请人：——

  公开号：US7977477B2

  公开（公告）日：2011-07-12